Abstract
In this chapter, we define N-of-1 trials and provide a brief historical perspective. We briefly cover the background and rationale for N-of-1 trials, and discuss their benefits.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Askew DA (2005). A study of research adequacy in Australian general practice. PhD thesis, The University of Queensland, Brisbane
Australian Council for Safety and Quality in Health Care (2006) National inpatient medication chart: general instructions/information for doctors. The Australian Department of Health and Ageing, Canberra
Centers for Chronic Disease Prevention and Health Promotion (2009) The power of prevention chronic disease….the public health challenge of the 21st century. http://www.cdc.gov/chronicdisease/pdf/2009-power-of-prevention.pdf. Accessed 31 Oct 2014
Commonwealth Department of Human Services and Health (2009) A policy on the quality use of medicines. Commonwealth Department of Human Services and Health, Canberra
Curry LC, Walker C, Hogstel MO, Burns P (2005) Teaching older adults to self manage medications: preventing adverse drug reactions. J Gerontol Nurs 31(4):32–42
Cushny AR, Peebles AR (1905) The action of optical isomers: II. Hyoscines. J Physiol 32(5–6):501–510
Facey K, Granados A, Guyatt G, Kent A, Shah N, van der Wilt GJ, Wong-Rieger D (2014) Generating health technology assessment evidence for rare diseases. Int J Technol Assess Health Care 19:1–7 [Epub ahead of print]
Gabler NB, Duan N, Vohra S, Kravitz RL (2011) N-of-1 trials in the medical literature: a systematic review. Med Care 49(8):761–768. doi:10.1097/MLR.0b013e318215d90d
Guyatt G, Sackett D, Taylor DW et al (1986) Determining optimal therapy: randomized trials in individual patients. N Engl J Med 314:889–892
Guyatt G, Sackett D, Adachi J et al (1988) A clinician’s guide for conducting randomized trials in individual patients. CMAJ 139:497–503
Guyatt GH et al (2000) Users′ guides to the medical literature: XXV. Evidence‐based medicine: principles for applying the users′ guides to patient care. Evidence‐based medicine working group. JAMA 284(10):1290–1296
Jayanthi LD, Ramamoorthy S (2005) Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants. AAPS J 7(3):E728–E738
Kellner R, Sheffield BF (1968) The use of self-rating scales in a single-patient multiple cross-over trial. Br J Psych 114(507):193–196
Larson EB (1990) N-of-1 clinical trials. A technique for improving medical therapeutics. West J Med 152:52–56
Larson EB, Ellsworth AJ, Oas J (1993) Randomised clinical trials in single patients during a 2–year period. JAMA 270(22):2708–2712
Mapel DW, Shainline M, Paez K, Gunter M (2004) Hospital, pharmacy and outpatient costs for osteoarthritis and chronic back pain. J Rheum 31(3):573–583
Mitchell G, Hardy J, Nikles J, Carmont S, Senior H, Schluter P, Good P, Currow D (2015) The effect of methylphenidate on fatigue in advanced cancer: an aggregated n-of-1 trial. J Pain Symptom Manage. doi:10.1016/j.jpainsymman.2015.03.009
Moulding N, Fahy N, Heng Foong L, Yeoh J, Silagy C, Weller D (1997) A systematic review of the current status of evidence-based medicine and its potential application to Australian general practice. A report to the Commonwealth Department of Health and Family Services. Department of General Practice, Flinders University
Nikles CJ, Clavarino AM, Del Mar CB (2005) Using N-of-1 trials as a clinical tool to improve prescribing. Br J Gen Pract 55(512):175–180
Nikles J, McKinlay L, Mitchell G, Carmont S-A, Senior H, Waugh M-C, Epps A, Schluter P, Lloyd O (2014) Aggregated N-of-1 trials of CNS stimulants versus placebo for paediatric traumatic brain injury – a pilot study. Trials 15:54
PBS expenditure and prescriptions, July 2012 to June 2013. Pharmaceutical benefits scheme website. http://www.pbs.gov.au/statistics/2012-2013-files/expenditure-and-prescriptions-12-months-to-30-06-2013.pdf. Accessed 31 Oct 2014
Roughead EE, Semple SJ (2009) Medication safety in acute care in Australia: where are we now? Part 1: a review of the extent and causes of medication problems 2002–2008. Australia and New Zealand Health Policy, 6. http://www.anzhealthpolicy.com/content/6/1/18. Accessed 18 Aug 2013
Sorensen L, Stokes JA, Purdie DM, Woodward M, Roberts MS (2005) Medication management at home: medication-related risk factors associated with poor health outcomes. Age Ageing 34(6):626–632
Walker JS, Sheather-Reid RB, Carmody JJ, Vial JH, Day RO (1997) Nonsteroidal anti-inflammatory drugs in rheumatoid arthritis and OA: support for the concept of “responders” and “nonresponders”. Art Rheum s40(11):1944–1954
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Nikles, J. (2015). What are N-of-1 Trials?. In: Nikles, J., Mitchell, G. (eds) The Essential Guide to N-of-1 Trials in Health. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-7200-6_2
Download citation
DOI: https://doi.org/10.1007/978-94-017-7200-6_2
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-7199-3
Online ISBN: 978-94-017-7200-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)